Home » Clinical Trials » TIARA: Autologous Tregs for Aplastic Anaemia

Research area:

Rare disease

Disease:

Aplastic anaemia

Intervention:

Therapeutics – ATMP

Phase:

Phase I

TIARA: Autologous Tregs for Aplastic Anaemia

Intervention

Therapeutics – ATMP

Funding awarded to

King’s College London

Public registration details (where available)

NCT05386264

Planned trial start and expected end date

July 2022 to September 2025

Related news

Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

Read more: Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

Read more: MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

UK Drug Discovery Consortium symposium

Read more: UK Drug Discovery Consortium symposium